Cargando…

Single nucleotide polymorphism rs 2070874 at Interleukin-4 is associated with increased risk of type 1 diabetes mellitus independently of human leukocyte antigens

INTRODUCTION: Type 1 diabetes mellitus (T1DM) is characterized by autoimmune destruction of insulin-producing pancreatic beta (β-) cells. Previous studies suggested an imbalance between and pro- and anti-inflammatory cytokines exacerbates T1DM development. OBJECTIVES: We aimed to test the hypothesis...

Descripción completa

Detalles Bibliográficos
Autores principales: Osman, Awad E, Brema, Imad, AlQurashi, Alaa, Al-Jurayyan, Abdullah, Bradley, Benjamin, Hamza, Muaawia A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006359/
https://www.ncbi.nlm.nih.gov/pubmed/35404688
http://dx.doi.org/10.1177/03946320221090330
_version_ 1784686648111398912
author Osman, Awad E
Brema, Imad
AlQurashi, Alaa
Al-Jurayyan, Abdullah
Bradley, Benjamin
Hamza, Muaawia A
author_facet Osman, Awad E
Brema, Imad
AlQurashi, Alaa
Al-Jurayyan, Abdullah
Bradley, Benjamin
Hamza, Muaawia A
author_sort Osman, Awad E
collection PubMed
description INTRODUCTION: Type 1 diabetes mellitus (T1DM) is characterized by autoimmune destruction of insulin-producing pancreatic beta (β-) cells. Previous studies suggested an imbalance between and pro- and anti-inflammatory cytokines exacerbates T1DM development. OBJECTIVES: We aimed to test the hypothesis that patients with T1DM carry a higher frequency of regulatory genes associated with low levels of the anti-inflammatory cytokines interleukin-4 (IL-4), its receptor (IL-4R), and interleukin-10 (IL-10). METHODS: Accordingly, we compared frequencies of five different single nucleotide polymorphisms (SNPs) in T1DM patients and healthy controls who had been typed for HLA-DRB1, HLA-DQA1, and HLA-DQB1 genes. RESULTS: The frequencies of rs2070874 (IL-4) alleles C and T differed between T1DM patients and controls ((c)p = 0.0065), as did their codominant ((c)p = 0.026) and recessive ((c)p = 0.015) models. Increased frequencies were observed in T1DM patients for HLA alleles: DRB1*03 (pc < 0.0013), DRB1*04 ((c)p = 0.0169), DQA1*03 ((c)p = 0.0222), DQA1*05 ((c)p < 0.0006), DQB1*02 ((c)p = 0.0005), and DQB1*06 ((c)p < 0.0005). And lower frequencies were observed for: DRB1*07 ((c)p = 0.0078), DRB1*11 ((c)p = 0.0013), DRB1*13 ((c)p < 0.0364), DRB1*15 ((c)p < 0.0013), DQA1*01 ((c)p < 0.0006), and DQA1*02 ((c)p = 0.0348). Certain DRB1: DQA1: DQB1 haplotypes showed greater frequencies, including, 03:05:02 (p < 0.0001) and 04:03:03 (p = 0.0017), whereas others showed lower frequencies, including, 07:02:02 (p = 0.0032), 11:05:03 (p = 0.0007), and 15:01:06 (p = 0.0002). Stratification for the above HLA haplotypes with rs2070874 C/C exhibited no significant differences between T1DM patients overall and controls. However, when stratified for the vulnerable HLA haplotype (03:05:02/04:03:03), young patients in whom T1DM began at ≤13 years had a higher frequency of the SNP (rs2070874 C/C); a gene associated with low IL-4 production (p < 0.024). CONCLUSION: This study suggests that possession of the rs2070874 C/C genotype, which is associated with low production of IL-4, increases the risk of T1DM in young individuals carrying vulnerable HLA alleles/haplotypes.
format Online
Article
Text
id pubmed-9006359
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-90063592022-04-14 Single nucleotide polymorphism rs 2070874 at Interleukin-4 is associated with increased risk of type 1 diabetes mellitus independently of human leukocyte antigens Osman, Awad E Brema, Imad AlQurashi, Alaa Al-Jurayyan, Abdullah Bradley, Benjamin Hamza, Muaawia A Int J Immunopathol Pharmacol Original Research Article INTRODUCTION: Type 1 diabetes mellitus (T1DM) is characterized by autoimmune destruction of insulin-producing pancreatic beta (β-) cells. Previous studies suggested an imbalance between and pro- and anti-inflammatory cytokines exacerbates T1DM development. OBJECTIVES: We aimed to test the hypothesis that patients with T1DM carry a higher frequency of regulatory genes associated with low levels of the anti-inflammatory cytokines interleukin-4 (IL-4), its receptor (IL-4R), and interleukin-10 (IL-10). METHODS: Accordingly, we compared frequencies of five different single nucleotide polymorphisms (SNPs) in T1DM patients and healthy controls who had been typed for HLA-DRB1, HLA-DQA1, and HLA-DQB1 genes. RESULTS: The frequencies of rs2070874 (IL-4) alleles C and T differed between T1DM patients and controls ((c)p = 0.0065), as did their codominant ((c)p = 0.026) and recessive ((c)p = 0.015) models. Increased frequencies were observed in T1DM patients for HLA alleles: DRB1*03 (pc < 0.0013), DRB1*04 ((c)p = 0.0169), DQA1*03 ((c)p = 0.0222), DQA1*05 ((c)p < 0.0006), DQB1*02 ((c)p = 0.0005), and DQB1*06 ((c)p < 0.0005). And lower frequencies were observed for: DRB1*07 ((c)p = 0.0078), DRB1*11 ((c)p = 0.0013), DRB1*13 ((c)p < 0.0364), DRB1*15 ((c)p < 0.0013), DQA1*01 ((c)p < 0.0006), and DQA1*02 ((c)p = 0.0348). Certain DRB1: DQA1: DQB1 haplotypes showed greater frequencies, including, 03:05:02 (p < 0.0001) and 04:03:03 (p = 0.0017), whereas others showed lower frequencies, including, 07:02:02 (p = 0.0032), 11:05:03 (p = 0.0007), and 15:01:06 (p = 0.0002). Stratification for the above HLA haplotypes with rs2070874 C/C exhibited no significant differences between T1DM patients overall and controls. However, when stratified for the vulnerable HLA haplotype (03:05:02/04:03:03), young patients in whom T1DM began at ≤13 years had a higher frequency of the SNP (rs2070874 C/C); a gene associated with low IL-4 production (p < 0.024). CONCLUSION: This study suggests that possession of the rs2070874 C/C genotype, which is associated with low production of IL-4, increases the risk of T1DM in young individuals carrying vulnerable HLA alleles/haplotypes. SAGE Publications 2022-04-11 /pmc/articles/PMC9006359/ /pubmed/35404688 http://dx.doi.org/10.1177/03946320221090330 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Research Article
Osman, Awad E
Brema, Imad
AlQurashi, Alaa
Al-Jurayyan, Abdullah
Bradley, Benjamin
Hamza, Muaawia A
Single nucleotide polymorphism rs 2070874 at Interleukin-4 is associated with increased risk of type 1 diabetes mellitus independently of human leukocyte antigens
title Single nucleotide polymorphism rs 2070874 at Interleukin-4 is associated with increased risk of type 1 diabetes mellitus independently of human leukocyte antigens
title_full Single nucleotide polymorphism rs 2070874 at Interleukin-4 is associated with increased risk of type 1 diabetes mellitus independently of human leukocyte antigens
title_fullStr Single nucleotide polymorphism rs 2070874 at Interleukin-4 is associated with increased risk of type 1 diabetes mellitus independently of human leukocyte antigens
title_full_unstemmed Single nucleotide polymorphism rs 2070874 at Interleukin-4 is associated with increased risk of type 1 diabetes mellitus independently of human leukocyte antigens
title_short Single nucleotide polymorphism rs 2070874 at Interleukin-4 is associated with increased risk of type 1 diabetes mellitus independently of human leukocyte antigens
title_sort single nucleotide polymorphism rs 2070874 at interleukin-4 is associated with increased risk of type 1 diabetes mellitus independently of human leukocyte antigens
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006359/
https://www.ncbi.nlm.nih.gov/pubmed/35404688
http://dx.doi.org/10.1177/03946320221090330
work_keys_str_mv AT osmanawade singlenucleotidepolymorphismrs2070874atinterleukin4isassociatedwithincreasedriskoftype1diabetesmellitusindependentlyofhumanleukocyteantigens
AT bremaimad singlenucleotidepolymorphismrs2070874atinterleukin4isassociatedwithincreasedriskoftype1diabetesmellitusindependentlyofhumanleukocyteantigens
AT alqurashialaa singlenucleotidepolymorphismrs2070874atinterleukin4isassociatedwithincreasedriskoftype1diabetesmellitusindependentlyofhumanleukocyteantigens
AT aljurayyanabdullah singlenucleotidepolymorphismrs2070874atinterleukin4isassociatedwithincreasedriskoftype1diabetesmellitusindependentlyofhumanleukocyteantigens
AT bradleybenjamin singlenucleotidepolymorphismrs2070874atinterleukin4isassociatedwithincreasedriskoftype1diabetesmellitusindependentlyofhumanleukocyteantigens
AT hamzamuaawiaa singlenucleotidepolymorphismrs2070874atinterleukin4isassociatedwithincreasedriskoftype1diabetesmellitusindependentlyofhumanleukocyteantigens